✦ LIBER ✦

Spironolactone versus nifedipine in essential hypertension

✍ Scribed by Michel Henry; Marie Wehrlen; Bruno Pelletier; Michel-Hubert Capron

Book ID: 113117038
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 258 KB
Volume: 65
Category: Article
ISSN: 0002-9149
DOI: 10.1016/0002-9149(90)91276-c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerance of spironolactone

Efficacy and tolerance of spironolactone in essential hypertension

✍ Xavier Jeunemaitre; Gilles Chatellier; Carmen Kreft-Jais; Anne Charru; Claude De 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 750 KB

Spironolactone and triamterene in volume

Spironolactone and triamterene in volume-dependent essential hypertension

✍ Decarvalho, José G R; Emery, Alfred C; Frohlich, Edward D 📂 Article 📅 1980 🏛 Nature Publishing Group 🌐 English ⚖ 275 KB

Nifedipine-prazosin interaction in patie

Nifedipine-prazosin interaction in patients with essential hypertension

✍ István Kiss; Csaba Farsang 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 255 KB

LONG TERM SPIRONOLACTONE AND THE ADRENAL

LONG TERM SPIRONOLACTONE AND THE ADRENAL CORTEX IN ESSENTIAL HYPERTENSION

✍ P. S. LEWIS; A. GORCHEIN; VIVIAN H. T. JAMES; C. N. MAY; C. E. HORTH 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Overlapping Spironolactone Dosing in Pri

Overlapping Spironolactone Dosing in Primary Aldosteronism and Resistant Essential Hypertension

✍ Joel Handler 📂 Article 📅 2012 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 150 KB

Morning versus evening administration of

Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension

✍ Greminger, P. ;Suter, P.M. ;Holm, D. ;Kobelt, R. ;Vetter, W. 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 576 KB

The nifedipine gastrointestinal therapeutic system (GITS) is a recently developed controlled-release formulation for once-a-day dosing. We evaluated the influence of morning versus evening administration of the drug in a randomized double-blind cross-over study including 15 essential hypertensives.